TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -6 | -4 | 10 | 8 | 28 | 6 | 7 |
| P | %wins | 0 | 0 | 50 | 50 | 100 | 50 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/14/15 16:16 | 12/11/15 | AKER | Akers Biosciences Inc | Health | Diagn | In Vitro & In Vivo Diagnostic | Rauch Gary M | NJ | O | VP - Fin | P | 5 | 1.50 | 0 | 4 | 233 | 5 | D | -54 | -68 | -54 | -50 | -25 | -25 | -4 | -5 | -5 | -9 | 33 | 35 | 26 | ||
8/25/14 15:50 | 8/22/14 | AKER | Akers Biosciences Inc | Health | Diagn | In Vitro & In Vivo Diagnostic | Rauch Gary M | NJ | O | VP of Fi | P | 3 | 3.15 | 0 | 1 | 213 | 2 | D | -34 | -20 | -21 | -8 | -9 | -2 | -6 | -2 | 29 | -17 | 20 | -15 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |